Over-the-counter drug · UNAPPROVED HOMEOPATHIC
Asthma Therapy NDC 17312-017
Strychnos nux-vomica seed 6 [hp_C]/1 + 6 more ingredients · Tablet, Orally disintegrating · Oral · TRP Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 17312-017-14 | 1731200171417312001714 | 1 BOTTLE in 1 PACKAGE (17312-017-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLEMarketed from Oct 30, 2012 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Asthma Therapy
- Generic name (nonproprietary)
- arsenic trioxide - histamine dihydrochloride - dermatophagoides pteronyssinus - magnesium phosphate, dibasic trihydrate - strychnos nux-vomica seed - aspidosperma quebracho-blanco bark - suplhur -
- Active ingredients
- Strychnos nux-vomica seed — 6 [hp_C]/1Aspidosperma quebracho-blanco bark — 6 [hp_C]/1Sulfur — 6 [hp_C]/1Arsenic trioxide — 6 [hp_C]/1Histamine dihydrochloride — 6 [hp_C]/1Dermatophagoides pteronyssinus — 6 [hp_C]/1Magnesium phosphate, Dibasic trihydrate — 6 [hp_C]/1
- Dosage form
- Tablet, Orally disintegrating
- Route
- Oral
- Labeler
- TRP CompanyNDC labeler code 17312
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved homeopathic
- Marketing start
- Listing expires
- Other FDA classes
- Allergens (Chemical structure)Allergens (Chemical structure)Dermatophagoides (Chemical structure)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased IgG Production (Physiologic effect)Increased IgG Production (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Insect Proteins (Chemical structure)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Plant Proteins (Chemical structure)Seed Storage Proteins (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 17312-017_4604ca9e-7244-adfd-e063-6394a90afa65SPL ID 4604ca9e-7244-adfd-e063-6394a90afa65SPL set ID 07d2988b-5012-481c-9b48-a709c33d2979UNII 269XH13919, 52B1340190, 70FD1KFU70, S7V92P67HO, 3POA0Q644U, 57L1Z5378K, HF539G9L3QUPC 0858961001174
- Pharmacologic class
- Calculi Dissolution Agent; Non-Standardized Plant Allergenic Extract; Osmotic Laxative; Standardized Insect Allergenic Extract
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N417312001714followed by a unit qualifier and the quantityPackage 17312-0017-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses According to homeopathic indications, these ingredients provide temporary relief of Asthma and COPD like symptoms such as: • Difficulty Breathing • Inflammation in the airways • Coughing • Wheezing • Shortness of breath • Sensation of tightness of the chest • Congestion after a diagnosis of Asthma or COPD by a physician.
Excerpt only. Read the full label for complete information.
About NDC 17312-017
- What is NDC 17312-017?
- 17312-017 is the product NDC for Asthma Therapy, Strychnos nux-vomica seed 6 [hp_C]/1 + 6 more ingredients tablet, orally disintegrating, listed with the FDA by TRP Company. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Asthma Therapy (Arsenic trioxide - histamine dihydrochloride - dermatophagoides pteronyssinus - magnesium phosphate, Dibasic trihydrate - strychnos nux-vomica seed - aspidosperma quebracho-blanco bark - suplhur -).
- What is the active ingredient?
- Strychnos nux-vomica seed, Aspidosperma quebracho-blanco bark, Sulfur, Arsenic trioxide, Histamine dihydrochloride, Dermatophagoides pteronyssinus, Magnesium phosphate, Dibasic trihydrate.
- Who is the labeler?
- TRP Company, NDC labeler code 17312. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Asthma Therapy?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.